An MRI brain atrophy and lesion index to assess the progression of structural changes in Alzheimers Disease, mild cognitive impairment, and normal aging: A follow-up study

Journal of Alzheimer's Disease

Volumn 26, Issue SUPPL. 3, 2011, Pages 359-367

  Zhang, Ningnannan ^a,b   Song, Xiaowei ^a,c   Zhang, Yunting ^b   Chen, Wei ^a,b   DArcy, Ryan C N ^a,c   Darvesh, Sultan ^c,d   Fisk, John D ^c,d   Rockwood, Kenneth ^c,d  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c DALHOUSIE UNIVERSITY   (Canada)

^d QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

Author keywords

aging; Alzheimers disease; atrophy; cognition; lesion; visual scale

Indexed keywords

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; BRAIN ATROPHY AND LESION INDEX; BRAIN DAMAGE; BRAIN REGION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MORPHOMETRICS; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RATING SCALE;

EID: 80055063880     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-0048     Document Type: Article

References (31)

1. Drayer BP (1988) Imaging of the aging brain. Part I. Normal findings. Radiology 166, 785-796. (Pubitemid 18058946)
2. Brickman AM, Zimmerman ME, Paul RH, Grieve SM, Tate DF, Cohen RA, Williams LM, Clark CR, Gordon E (2006) Regional white matter and neuropsychological functioning across the adult lifespan. Biological Psychiatry 60, 444-453. (Pubitemid 44292161)
3. Duara R, Loewenstein DA, Potter E, Appel J, Greig MT, Urs R, Shen Q, Raj A, Small B, Barker W, Schofield E, Wu Y, Potter H (2008) Medial temporal lobe atrophy on MRI scans and the diagnosis of Alzheimer disease. Neurology 71, 1986-1992.
4. Brickman AM, Muraskin J, Zimmerman ME (2009) Structural neuroimaging in Alzhmeimers disease: do white matter hyperintensities matter? Dialogues Clin Neurosci 11, 181-190.
5. Black S, Gao F, Bilbao J (2009) Understanding white matter disease: imaging-pathological correlations in vascular cognitive impairment. Stroke 40, S48-S52.
6. Savva GM, Wharton SB, Ince PG, Forster G, Matthews FE, Brayne C, Medical Research Council Cognitive Function, Ageing, Study (2009) Age, neuropathology, and dementia. N Engl J Med 360, 2302-2309.
7. White L (2009) Brain lesions at autopsy in older Japanese-American men as related to cognitive impairment and dementia in the final years of life: a summary report from the Honolulu-Asia aging study. J Alzheimers Dis 18, 713-725.
8. Capizzano AA, Acion L, Bekinschtein T, Furman M, Gomila H, Martinez A, Mizrahi R, Starkstein SE (2004) White matter hyperintensities are significantly associated with cortical atrophy in Alzheimers disease. J Neurol Neurosurg Psychiatry 75, 822-827. (Pubitemid 38658501)
9. Jack CR Jr, Shiung MM, Gunter JL, OBrien PC, Weigand SD, Knopman DS, Boeve BF, Ivnik RJ, Smith GE, Cha RH, Tangalos EG, Petersen RC (2004) Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Neurology 62, 591-600. (Pubitemid 38252801)
10. Kapeller P, Barber R,Vermeulen J, Ader H, Scheltens P, Freidl W, Almkvist O, Moretti M, del Ser T, Vaghfeldt P, Enzinger C, Barkhof F, Inzitari D, Erkinjunti T, Schmidt R, Fazekas F (2003) European Task Force of Age Related White Matter Changes, Visual rating of age-related white matter changes on magnetic resonance imaging: scale comparison, interrater agreement, and correlations with quantitative measurements. Stroke 34, 441-445. (Pubitemid 36210903)
11. Wahlund LO, Barkhof F, Fazekas F, Bronge L, Augustin M, Sjögren M, Wallin A, Ader H, Leys D, Pantoni L, Pasquier F, Erkinjuntti T, Scheltens P (2001) European Task Force on Age-Related White Matter Changes, A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 32, 1318-1322. (Pubitemid 32530416)
12. Scheltens P, Barkhof F, Leys D, Pruvo JP, Nauta JJ, Vermersch P, Steinling M, Valk J (1993) A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J Neurol Sci 114, 7-12. (Pubitemid 23025201)
13. Alvarez-Linera J (2008) 3T MRI: advances in brain imaging. Eur J Radiol 67, 415-426.
14. Duyn JH (2010) Study of brain anatomy with high-field MRI: recent progress. Magn Reson Imaging 28, 1210-1215.
15. ChenW, Song X, Zhang Y, Darvesh S, Zhang N, DArcy RC, Black S, Rockwood K (2010) An MRI-based semiquantitative index for the evaluation of brain atrophy and lesions in Alzheimers disease, mild cognitive impairment and normal aging. Dement Geriatr Cogn Disord 30, 121-130.
16. den Heijer T, van der Lijn F, Koudstaal PJ, Hofman A, van der Lugt A, Krestin GP, Niessen WJ, Breteler MM (2010) A 10-year follow-up of hippocampal volume on magnetic resonance imaging in early dementia and cognitive decline. Brain 133, 1163-1172.
17. Whitwell JL, Przybelski SA, Weigand SD, Knopman DS, Boeve BF, Petersen RC, Jack CR Jr (2007) 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimers disease. Brain 130, 1777-1786. (Pubitemid 47343806)
18. Silbert LC, Howieson DB, Dodge H, Kaye JA (2009) Cognitive impairment risk: white matter hyperintensity progression matters. Neurology 73, 120-125.
19. Werner MW, Aisen PS, Jack CR Jr, Jagust WJ, Trojanowski JQ, Shaw L, Saykin AJ, Morris JC, Cairns N, Beckett LA, Toga A, Green R, Walter S, Soares H, Snyder P, Siemers E, Potter W, Cole PE, Schmidt M (2010) Alzheimers Disease Neuroimaging Initiative, The Alzheimers disease neuroimaging initiative: progress report and future plans. Alzheimers Dement 6, 201-211.
20. Jack CR Jr, Bernstein MA, Fox NC, Thompson P, Alexander G, Harvey D, Borowski B, Britson PJ, Whitwell JL, Ward C, Dale AM, Felmlee JP, Gunter JL, Hill DL, Killiany R, Schuff N, Fox-Bosetti S, Lin C, Studholme C, DeCarli CS, Krueger G, Ward HA, Metzger GJ, Scott KT, Mallozzi R, Blezek D, Levy J, Debbins JP, Fleisher AS, Albert M, Green R, Bartzokis G, Glover G, Mugler J,WeinerMW(2008) The Alzheimers Disease Neuroimaging Initiative (ADNI): MRI methods. J Magn Reson Imaging 27, 685-691. (Pubitemid 351508080)
21. ADNIGeneral Procedures Manual, http://www.loni.ucla.edu/ research/protocols/clinical-protocols/ADNI General Procedures Manual.pdf.
22. van der Flier WM, Middelkoop HA, Weverling-Rijnsburger AW, Admiraal-Behloul F, Spilt A, Bollen EL, Westendorp RG, van Buchem MA (2004) Interaction of medial temporal lobe atrophy and white matter hyperintensities in AD. Neurology 62, 1862-1864. (Pubitemid 38661753)
23. Sean MN, Raul R, Michael B, Smith M, Accomazzi V,Wells JL, Fogarty J, Bartha R (2008) Alzheimers Disease Neuroimaging Initiative, Ventricular enlargement as a possible measure of Alzheimers disease progression validated using the Alzheimers disease neuroimaging initiative database. Brain 131, 2443-2454.
24. Driscoll I, Davatzikos C, An Y, Wu X, Shen D, Kraut M, ResnickSM(2009) Longitudinal pattern of regional brain volume change differentiates normal aging from MCI. Neurology 72, 1906-1913.
25. Ezekiel F, Chao L, Kornak J, Du AT, Cardenas V, Truran D, Jagust W, Chui H, Miller B, Yaffe K, Schuff N, Weiner M (2004) Comparisons between global and focal brain atrophy rates in normal aging and Alzheimer disease: Boundary Shift Integral versus tracing of the entorhinal cortex and hippocampus. Alzheimer Dis Assoc Disord 18, 196-201. (Pubitemid 40076148)
26. DeCarli C, Fletcher E, Ramey V, Harvey D, Jagust WJ (2005) Anatomical Mapping of White Matter Hyperintensities (WMH). Exploring the relationships between periventricular WMH, deep WMH, and total WMH burden. Stroke 36, 50-55.
27. Brickman AM, Honig LS, Scarmeas N, Tatarina O, Sanders L, Albert MS, Brandt J, Blacker D, Stern Y (2008) Measuring cerebral atrophy and white matter hyperintensity burden to predict the rate of cognitive decline in Alzheimer disease. Archives of neurology 65, 1202-208.
28. Stern Y (2009) Cognitive reserve. Neuropsychologia 47, 2015-2028.
29. Gouw AA, van der Flier WM, van Straaten EC, Pantoni L, Bastos-Leite AJ, Inzitari D, Erkinjuntti T, Wahlund LO, Ryberg C, Schmidt R, Fazekas F, Scheltens P, Barkhof F; LADISstudy group (2008) Reliability and sensitivity of visual scales versus volumetry for evaluating white matter hyperintensity progression. Cerebrovasc Dis 25, 247-253. (Pubitemid 351450428)
30. Enzinger C, Fazekas F, Matthews PM, Ropele S, Schmidt H, Smith S, Schmidt R (2005) Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects. Neurology 24, 1704-1711. (Pubitemid 40695802)
31. Frisoni GB, Fox NC, Jack CR Jr, Scheltens P, Thompson PM (2010) The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol 6, 67-77.